Apogee Therapeutics, Inc. (APGE)

NGM – Real Time Price. Currency in USD

82.93

-1.67 (-1.97%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-1M

-189K

Gross Profit

-1M

-189K

Operating expenses (excl. COGS)

-284M

-217M

-93M

-31M

Operating Income

-286M

-217M

-93M

-31M

Non-operating income, total

30M

35M

-9M

Pretax income

-256M

-182M

-84M

-40M

Equity in earnings

Taxes

-278K

-18K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-256M

-182M

-84M

-40M

Apogee Therapeutics, Inc. (APGE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Apogee Therapeutics, Inc. (APGE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Apogee Therapeutics, Inc. (APGE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Apogee Therapeutics, Inc. (APGE)

Income Statement (Annual)

Income Statement (Annual)